BPA Call 36E79718A0010-36C26219F0172
Award Date 12/7/18
Potential Completion Date 12/13/20
Potential Value $112K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Los Angeles, CA 90037, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for a Blanket Purchase Agreement (BPA) call from the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 7 to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract is for the delivery of Prolastin, a pharmaceutical product, with a potential value of $125,209.92. The contract does not utilize any small business set-asides and is a Firm Fixed...
- This contract was awarded by the Department of Veterans Affairs Veterans Health Administration to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed price, for the delivery of the pharmaceutical product PROLASTIN. The contract has a potential value of $203,986.73 and a completion date of February 6, 2021. The contract was awarded on February 7, 2020 and does not...
- This is a contract award by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract is a Blanket Purchase Agreement (BPA) call for the delivery of the pharmaceutical product Prolastin, with a potential value of $110,496.96. The contract is not designated as a set-aside and utilizes the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB) as the parent...
- This is a federal contract award from the U.S. Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The $98,175.36 firm-fixed-price delivery order is for the provision of various pharmaceutical products, including Prolastin, Prolastin-C, and immune globulin, to the VA's Integrated Service Network 19. The contract is a delivery order placed against the Pharmaceuticals and Drugs Federal Supply Schedule...
- The Department of Veterans Affairs Veterans Health Administration awarded Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals, a $130,406.43 delivery order contract for PROLASTIN 1000MG/VIAL. The contract is a firm fixed price agreement issued under the Pharmaceuticals and Drugs GSA Schedule. This award does not utilize a small business set-aside. Grifols has previously provided pharmaceutical products such as Prolastin, Prolastin-C, and...
- This is a federal contract award for PROLASTIN to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract, valued at $219,999.96, was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 20 and did not utilize any small business set-asides. The contract is a delivery order under the Pharmaceuticals and Drugs General Services Administration (GSA) Federal Supply...
- The Department of Veterans Affairs Veterans Health Administration awarded a delivery order contract to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals, for the provision of the drug PROLASTIN. The $202,942.32 firm fixed price contract is a delivery order issued under Grifols' Pharmaceuticals and Drugs GSA Schedule contract. The contract does not utilize any small business set-asides and has a performance period ending on April 15,...
- This federal contract award was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The $639,352.61 Blanket Purchase Agreement (BPA) call contract is for the delivery of medication, specifically pharmaceuticals and drugs, under the General Services Administration (GSA) Pharmaceuticals and Drugs Schedule. The contract does...
- This federal contract award is a delivery order issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The order is for various pharmacy supplies and pharmaceuticals, including Prolastin, Prolastin-C, and immune globulin, under the Pharmaceuticals and Drugs General Services Administration (GSA) Schedule contract. The total...
- This federal contract award is for PROLASTIN-C, a pharmaceutical product, awarded by the Department of Veterans Affairs Veterans Health Administration to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The $355,273.02 firm fixed price delivery order is under the Pharmaceuticals and Drugs GSA Schedule contract vehicle and does not utilize any small business set-asides. Grifols Therapeutics has previously been awarded other federal...